Interleukin (IL)-6 has been studied since its discovery for its role in health and diseases. It is
one of the most important pro-inflammatory cytokines. IL-6 was reported as an exacerbating …

The detrimental impact of obesity on human health is increasingly evident with the rise in
obesity-related diseases. Skeletal muscle, the crucial organ responsible for energy balance …

There is still a significant lack of knowledge regarding many aspects of the etiopathology
and consequences of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …

Background and purpose Little is known about whether nonalcoholic fatty liver disease
(NAFLD) is associated with dementia or the role of serum proinflammatory cytokines in the …

Acute myeloid leukemia (AML), an aggressive hematopoietic malignancy, exhibits poor
prognosis and a high recurrence rate largely because of primary and secondary drug …

Non-alcoholic fatty liver disease (NAFLD) is emerging as one of the most common chronic
liver diseases worldwide, affecting 25% of the world population. In recent years, there has …

Many people living with diabetes also have nonalcoholic fatty liver disease (NAFLD).
Interleukin-6 (IL-6) is involved in both diseases, interacting with both membrane-bound …

Growing evidence indicates that silibinin (SLB), a main component extracted from Chinese
herb Silybum marianum, can effectively antagonize doxorubicin (DOX) induced myocardial …

Background & purpose Non-alcoholic fatty liver disease (NAFLD) is characterised by the
excessive accumulation of triglycerides in the liver. Shenling Baizhu powder (SLBZP) is …

Background: Interleukin-6 receptor (IL-6R) blockade has been approved for inflammation-
associated diseases and whether it is effective in treating non-alcoholic fatty liver disease …